Publications
5538 Results
- Journal / Conference
- Blood 92(2):589-595
- Year
- 1998
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8600
Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion protein.
- Journal / Conference
- Journal of Clinical Oncology 16(6):2289-2290
- Year
- 1998
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-9246
Paclitaxel for the treatment of lymphoma.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 17:101a(#390a)
- Year
- 1998
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9410 (INT-0148) (CALGB-9344)
Improved disease-free (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients (pts) with node-positive primary breast cancer (BC).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 17:456a(#1753)
- Year
- 1998
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9221 (MDACC, ID91-025) (INT-I91-0001)
Phase III intergroup trial of 13-cis-retinoic acid to prevent second primary tumors in stage-I non-small cell lung cancer (NSCLC): Interim report of NCI #191-0001.
- Journal / Conference
- Journal of Clinical Oncology 16(4):1287-1293
- Year
- 1998
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8997 (EST-3887) (ECOG-3887)
Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B study.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 17:256a(#982)
- Year
- 1998
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8899 (INT-0089)
Fluorouracil (FU), leucovorin (LV), and levamisole (LEV) adjuvant therapy for colon cancer: Five-year final report of INT-0089.
- Journal / Conference
- American Society of Clinical Oncology Education Book :253-259
- Year
- 1998
Interpreting clinical trials 2: Factorial designs, subset analyses, and intent to treat.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 17:457a(#1757
- Year
- 1998
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8991 (EST-3588) (RTOG-8815) (INT-0096)
Observations after 5 year follow-up of intergroup trial 0096: 4 cycles of cisplatin(P) etoposide (E) and concurrent 45 GY thoracic radiotherapy (TRT) given in daily (QD) or twice-daily fractions followed by 25 GY PCI. Survival differencs and patterns of failure.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 17:458a(#1764)
- Year
- 1998
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8991 (EST-3588) (RTOG-8815) (INT-0096)
Incidence and clinical significance of variant morphology (small cell/large cell subtype) in limited stage small cell lung cancer (SCLC). A prospective analysis of an intergroup ECOG, RTOG and SWOG study.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 17:30a(#118)
- Year
- 1998
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9449 (INT-0156) (E1C93)